Health committee  Yes. I can add that my good friend and colleague Dr. John Stoessl also appeared before this committee, and I want to second his comments. I think they were in response to a request from you, Ms. Duncan. I think the time is right to establish a consortium of networks of excellence for neurological disease and ideally for neuro-degenerative diseases.

Health committee  I think that should be a strong recommendation.

Health committee  Absolutely.

Health committee  It certainly is.

Health committee  You want the ten-second answer? It's not enough.

Health committee  Thank you very much for that question. I think you're absolutely right, and it's really been a shift in the way we think about Parkinson's disease. Literally 15 years ago people were completely focused on the motor components—the tremor, the slowness in movement. As we've gotten better at treating those parts of the disease, it's become very clear that patients have many other features.

Health committee  Thank you, Madam Chair. Esteemed members of the committee, thank you very much for giving me this opportunity to meet with you. As director of the McGill Parkinson program and as a practising neurologist, I am confronted daily with the progressive disability and suffering of patients afflicted with this devastating chronic illness, as people like Mr.